Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VAXNEUVANCE safely and effectively. See full prescribing information for VAXNEUVANCE. VAXNEUVANCE® (Pneumococcal 15-valent Conjugate Vaccine)injectable suspension, for intramuscular useInitial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-other
VAXNEUVANCE® is indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 6 weeks of age and older.
- generic_name
- pneumococcal 15-valent conjugate vaccine crm197 protein adsorbed
- product_names
- Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed
- ndc
- 0006-4329, 0006-4329-01, 0006-4329-03, 0006-4329-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en